Literature DB >> 27313209

Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system.

Hyeseok Shim1, Chuan Wu2, Shivan Ramsamooj3, Kaitlyn N Bosch3, Zuojia Chen2, Brooke M Emerling3, Jihye Yun3, Hui Liu4, Rayman Choo-Wing3, Zhiwei Yang3, Gerburg M Wulf4, Vijay Kumar Kuchroo2, Lewis C Cantley5.   

Abstract

Type 2 phosphatidylinositol-5-phosphate 4-kinase (PI5P4K) converts phosphatidylinositol-5-phosphate to phosphatidylinositol-4,5-bisphosphate. Mammals have three enzymes PI5P4Kα, PI5P4Kβ, and PI5P4Kγ, and these enzymes have been implicated in metabolic control, growth control, and a variety of stress responses. Here, we show that mice with germline deletion of type 2 phosphatidylinositol-5-phosphate 4-kinase gamma (Pip4k2c), the gene encoding PI5P4Kγ, appear normal in regard to growth and viability but have increased inflammation and T-cell activation as they age. Immune cell infiltrates increased in Pip4k2c(-/-) mouse tissues. Also, there was an increase in proinflammatory cytokines, including IFNγ, interleukin 12, and interleukin 2 in plasma of Pip4k2c(-/-) mice. Pip4k2c(-/-) mice had an increase in T-helper-cell populations and a decrease in regulatory T-cell populations with increased proliferation of T cells. Interestingly, mammalian target of rapamycin complex 1 (mTORC1) signaling was hyperactivated in several tissues from Pip4k2c(-/-) mice and treating Pip4k2c(-/-) mice with rapamycin reduced the inflammatory phenotype, resulting in a decrease in mTORC1 signaling in tissues and a decrease in proinflammatory cytokines in plasma. These results indicate that PI5P4Kγ plays a role in the regulation of the immune system via mTORC1 signaling.

Entities:  

Keywords:  PI5P4K; PIP4K2C; autoimmunity; inflammation; mTORC1

Mesh:

Substances:

Year:  2016        PMID: 27313209      PMCID: PMC4941458          DOI: 10.1073/pnas.1600934113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  PIP4Kbeta interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kalpha.

Authors:  Yvette Bultsma; Willem-Jan Keune; Nullin Divecha
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

2.  Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation.

Authors:  V D Rao; S Misra; I V Boronenkov; R A Anderson; J H Hurley
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

3.  Activation of a metabolic gene regulatory network downstream of mTOR complex 1.

Authors:  Katrin Düvel; Jessica L Yecies; Suchithra Menon; Pichai Raman; Alex I Lipovsky; Amanda L Souza; Ellen Triantafellow; Qicheng Ma; Regina Gorski; Stephen Cleaver; Matthew G Vander Heiden; Jeffrey P MacKeigan; Peter M Finan; Clary B Clish; Leon O Murphy; Brendan D Manning
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

4.  The flattened face of type II beta phosphatidylinositol phosphate kinase binds acidic phospholipid membranes.

Authors:  L M Burden; V D Rao; D Murray; R Ghirlando; S D Doughman; R A Anderson; J H Hurley
Journal:  Biochemistry       Date:  1999-11-16       Impact factor: 3.162

5.  Proinflammatory T helper type 17 cells are effective B-cell helpers.

Authors:  Meike Mitsdoerffer; Youjin Lee; Anneli Jäger; Hye-Jung Kim; Thomas Korn; Jay K Kolls; Harvey Cantor; Estelle Bettelli; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- mice.

Authors:  Katja A Lamia; Odile D Peroni; Young-Bum Kim; Lucia E Rameh; Barbara B Kahn; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus.

Authors:  E Y M G Fung; D J Smyth; J M M Howson; J D Cooper; N M Walker; H Stevens; L S Wicker; J A Todd
Journal:  Genes Immun       Date:  2008-12-25       Impact factor: 2.676

8.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

9.  Common variants at CD40 and other loci confer risk of rheumatoid arthritis.

Authors:  Soumya Raychaudhuri; Elaine F Remmers; Annette T Lee; Rachel Hackett; Candace Guiducci; Noël P Burtt; Lauren Gianniny; Benjamin D Korman; Leonid Padyukov; Fina A S Kurreeman; Monica Chang; Joseph J Catanese; Bo Ding; Sandra Wong; Annette H M van der Helm-van Mil; Benjamin M Neale; Jonathan Coblyn; Jing Cui; Paul P Tak; Gert Jan Wolbink; J Bart A Crusius; Irene E van der Horst-Bruinsma; Lindsey A Criswell; Christopher I Amos; Michael F Seldin; Daniel L Kastner; Kristin G Ardlie; Lars Alfredsson; Karen H Costenbader; David Altshuler; Tom W J Huizinga; Nancy A Shadick; Michael E Weinblatt; Niek de Vries; Jane Worthington; Mark Seielstad; Rene E M Toes; Elizabeth W Karlson; Ann B Begovich; Lars Klareskog; Peter K Gregersen; Mark J Daly; Robert M Plenge
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

10.  Localization of phosphatidylinositol phosphate kinase IIgamma in kidney to a membrane trafficking compartment within specialized cells of the nephron.

Authors:  Jonathan H Clarke; Piers C Emson; Robin F Irvine
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27
View more
  21 in total

1.  A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis.

Authors:  Gaurav Sharma; Carlos M Guardia; Ajit Roy; Alex Vassilev; Amra Saric; Lori N Griner; Juan Marugan; Marc Ferrer; Juan S Bonifacino; Melvin L DePamphilis
Journal:  Autophagy       Date:  2019-03-08       Impact factor: 16.016

2.  Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors.

Authors:  Sindhu Carmen Sivakumaren; Hyeseok Shim; Tinghu Zhang; Fleur M Ferguson; Mark R Lundquist; Christopher M Browne; Hyuk-Soo Seo; Marcia N Paddock; Theresa D Manz; Baishan Jiang; Ming-Feng Hao; Pranav Krishnan; Diana G Wang; T Jonathan Yang; Nicholas P Kwiatkowski; Scott B Ficarro; James M Cunningham; Jarrod A Marto; Sirano Dhe-Paganon; Lewis C Cantley; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2020-03-03       Impact factor: 8.116

3.  Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.

Authors:  Theresa D Manz; Sindhu C Sivakumaren; Adam Yasgar; Matthew D Hall; Mindy I Davis; Hyuk-Soo Seo; Joseph D Card; Scott B Ficarro; Hyeseok Shim; Jarrod A Marto; Sirano Dhe-Paganon; Atsuo T Sasaki; Matthew B Boxer; Anton Simeonov; Lewis C Cantley; Min Shen; Tinghu Zhang; Fleur M Ferguson; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2019-11-03       Impact factor: 4.345

4.  Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.

Authors:  Theresa D Manz; Sindhu Carmen Sivakumaren; Fleur M Ferguson; Tinghu Zhang; Adam Yasgar; Hyuk-Soo Seo; Scott B Ficarro; Joseph D Card; Hyeseok Shim; Chandrasekhar V Miduturu; Anton Simeonov; Min Shen; Jarrod A Marto; Sirano Dhe-Paganon; Matthew D Hall; Lewis C Cantley; Nathanael S Gray
Journal:  J Med Chem       Date:  2020-04-27       Impact factor: 7.446

5.  Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.

Authors:  Mark R Lundquist; Marcus D Goncalves; Ryan M Loughran; Elite Possik; Tarika Vijayaraghavan; Annan Yang; Chantal Pauli; Archna Ravi; Akanksha Verma; Zhiwei Yang; Jared L Johnson; Jenny C Y Wong; Yilun Ma; Katie Seo-Kyoung Hwang; David Weinkove; Nullin Divecha; John M Asara; Olivier Elemento; Mark A Rubin; Alec C Kimmelman; Arnim Pause; Lewis C Cantley; Brooke M Emerling
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

6.  Pharmacological inhibition of PI5P4Kα/β disrupts cell energy metabolism and selectively kills p53-null tumor cells.

Authors:  Song Chen; Caroline Chandra Tjin; Xiang Gao; Yi Xue; Haoyan Jiao; Ruilin Zhang; Mengnan Wu; Zunyu He; Jonathan Ellman; Ya Ha
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

7.  Therapeutic Delivery of Pip4k2c-Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart.

Authors:  Ajit Magadum; Neha Singh; Ann Anu Kurian; Mohammad Tofael Kabir Sharkar; Nishat Sultana; Elena Chepurko; Keerat Kaur; Magdalena M Żak; Yoav Hadas; Djamel Lebeche; Susmita Sahoo; Roger Hajjar; Lior Zangi
Journal:  Adv Sci (Weinh)       Date:  2021-03-12       Impact factor: 17.521

8.  Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.

Authors:  Evan K Noch; Isaiah Yim; Teresa A Milner; Lewis C Cantley
Journal:  J Comp Neurol       Date:  2020-06-26       Impact factor: 3.215

9.  PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay.

Authors:  Archna Ravi; Lavinia Palamiuc; Ryan M Loughran; Joanna Triscott; Gurpreet K Arora; Avi Kumar; Vivian Tieu; Chantal Pauli; Matthias Reist; Rachel J Lew; Shauna L Houlihan; Christof Fellmann; Christian Metallo; Mark A Rubin; Brooke M Emerling
Journal:  Dev Cell       Date:  2021-05-12       Impact factor: 13.417

10.  PIP4Ks impact on PI3K, FOXP3, and UHRF1 signaling and modulate human regulatory T cell proliferation and immunosuppressive activity.

Authors:  Alessandro Poli; Shidqiyyah Abdul-Hamid; Antonio Enrico Zaurito; Francesca Campagnoli; Valeria Bevilacqua; Bhavwanti Sheth; Roberta Fiume; Massimiliano Pagani; Sergio Abrignani; Nullin Divecha
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.